Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

NIH Seeks Input On Financial Conflicts

by Britt E. Erickson
May 18, 2009 | A version of this story appeared in Volume 87, Issue 20

NIH is requesting public comments on whether to revise its current financial conflict-of-interest (FCOI) regulations, which were implemented in 1995. The agency is particularly interested in whether to expand the scope of the regulations, how to define "significant financial interest," and the role of institutions in identifying and managing conflicts. NIH is facing pressure from some members of Congress to finalize its FCOI regulations before it hands out $8.2 billion in stimulus money for extramural research. And Sens. Charles E. Grassley (R-Iowa) and Herb Kohl (D-Wis.) recently urged NIH to require disclosure of financial relationships between drug manufacturers and doctors who conduct federally funded medical research. NIH is accepting comments until July 7.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.